Aim immunotech ceo to participate in two upcoming investor conferences

Ocala, fla., dec. 06, 2021 (globe newswire) -- aim immunotech inc. (nyse american: aim) today announced that thomas equels, chief executive officer of aim, will be participating in two upcoming investor conferences.

AIM Ratings Summary

AIM Quant Ranking